This information was published on 2026-03-04T11:27:28 for IP Right Registration Published.
| Field | Value |
| (210) | 2595327 (IR 1881624) |
| (220) |
04 Aug 2025
|
| (300) |
IT, 24 Jul 2025, 302025000118927
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical drugs; medicines; chemical preparations for pharmaceutical purposes; biological preparations for medical purposes; chemico-pharmaceutical preparations; biological reagents for medical purposes; vaccines; nucleic acid-based pharmaceutical and veterinary products; food and dietary substances for medical or veterinary use; therapeutic antibodies; dietary supplements and preparations; pharmaceutical and natural medicines; nucleic acid-based preparations; cell-based preparations; tissue-based preparations; biological preparations; biological preparations for medical and pharmaceutical use; diagnostic preparations; engineered biological tissues for medical purposes; sanitary preparations for medical purposes; advanced therapy medicinal products; personalized medicine products; regenerative medicine products; somatic cell therapy products; gene therapy products; recombinant human protein being biochemical preparations and nucleic acid sequences for medical use. Class 42 Research and development of vaccines and nucleic acid-based medicines; scientific and technological services; research services in the medical and pharmaceutical fields; development of pharmaceutical preparations and medicines; development of pharmaceutical reagents and medicines; providing information and data relating to medical and veterinary research and development; medical laboratories; design and development of hardware and software; research and development in the biochemical and nucleic acid fields; research and development services in the field of microorganisms and cells; research and development services in the field of diagnostic preparations; research and development in the pharmaceutical and biotechnological sector; research and development services for the pharmaceutical industry; scientific research in the biological field; research on medicines; research on reagents; medical research laboratory services; research services for the development of new pharmaceutical products and advanced therapies; development of biological drugs and advanced therapies; biological and chemical analysis in the medical and pharmaceutical fields. |
| (540) | AMCAP |
| (550) | Word |
| (730) |
ANEMOCYTE S.R.L.
|
Find out more about publications on the About page.